A top pharmaceutical lobbying group is launching an ad campaign to defend drugmakers that have been under fire for their pricing practices.

Patients are behaving more like consumers when it comes to healthcare, which presents a unique opportunity to make health “cooler,” according to Kaiser Permanente CEO Bernard Tyson.

Pop quiz: Are the Obamacare exchanges a success? Your answer should take into account three recent pieces of news about the online marketplaces created by the Affordable Care Act:

Americans have expressed outrage at drug companies for raising prices on products like EpiPen, the severe allergy treatment needed by thousands of children, and Daraprim, a rarely used but essential drug to treat a parasitic infection.

People struck by surprise medical bills are easy to find.

In late summer, after the Democratic National Convention ended, a powerful trade group in Washington had a message for its industry: Hillary Clinton, at that moment, was likely to win the White House.